129 related articles for article (PubMed ID: 8629264)
1. [Hodgkin disease--pathogenesis and therapy].
Wolf J; Diehl V
Ther Umsch; 1996 Feb; 53(2):140-6. PubMed ID: 8629264
[TBL] [Abstract][Full Text] [Related]
2. [Clinical aspects and primary therapy of Hodgkin's lymphomas].
Sieber M; Tesch H; Diehl V
Praxis (Bern 1994); 1996 Mar; 85(12):364-70. PubMed ID: 8643899
[TBL] [Abstract][Full Text] [Related]
3. Advances in biology, diagnostics, and treatment of Hodgkin's disease.
Küppers R; Yahalom J; Josting A
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):66-76. PubMed ID: 16399588
[TBL] [Abstract][Full Text] [Related]
4. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
5. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease: from basic science to clinical application.
Tesch H; Diehl V
Leukemia; 1996 Jun; 10 Suppl 2():s74-7. PubMed ID: 8649058
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus in Hodgkin's disease: more than just an innocent bystander.
Oudejans JJ; Jiwa NM; Meijer CJ
J Pathol; 1997 Apr; 181(4):353-6. PubMed ID: 9196428
[TBL] [Abstract][Full Text] [Related]
8. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
Laport GF; Williams SF
Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
[TBL] [Abstract][Full Text] [Related]
10. The clonal relationship between nodular sclerosis Hodgkin's disease with a clonal Reed-Sternberg cell population and a subsequent B-cell small noncleaved cell lymphoma.
Ohno T; Trenn G; Wu G; Abou-Elella A; Reis HE; Chan WC
Mod Pathol; 1998 May; 11(5):485-90. PubMed ID: 9619603
[TBL] [Abstract][Full Text] [Related]
11. Classical Hodgkin and Reed-Sternberg cells demonstrate a non-clonal immature B lymphoid lineage: evidence from a single cell assay and in situ hybridization.
Ohshima K; Suzumiya J; Mukai Y; Tashiro K; Shibata T; Tanaka T; Kato A; Kikuchi M
Hematol Oncol; 1996 Sep; 14(3):123-36. PubMed ID: 9119357
[TBL] [Abstract][Full Text] [Related]
12. [Presence of human cytomegalovirus within the neoplastic cells of Hodgkin's disease].
Huang GS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):403-5. PubMed ID: 12940088
[TBL] [Abstract][Full Text] [Related]
13. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
14. [Medicinal therapy of malignant lymphomas].
Aul C; Schroeder M; Giagounidis A
Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
[TBL] [Abstract][Full Text] [Related]
15. Human herpesvirus 6 and Epstein-Barr virus in Hodgkin's disease: a controlled study by polymerase chain reaction and in situ hybridization.
Valente G; Secchiero P; Lusso P; Abete MC; Jemma C; Reato G; Kerim S; Gallo RC; Palestro G
Am J Pathol; 1996 Nov; 149(5):1501-10. PubMed ID: 8909240
[TBL] [Abstract][Full Text] [Related]
16. Hodgkin's disease revisited: Reed-Sternberg cells as natural hybridomas.
Sinkovics JG
Crit Rev Immunol; 1991; 11(1):33-63. PubMed ID: 1652972
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
Chapman AL; Rickinson AB; Thomas WA; Jarrett RF; Crocker J; Lee SP
Cancer Res; 2001 Aug; 61(16):6219-26. PubMed ID: 11507075
[TBL] [Abstract][Full Text] [Related]
18. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
Kuljić-Kapulica N
Srp Arh Celok Lek; 1998; 126(3-4):97-100. PubMed ID: 9863363
[TBL] [Abstract][Full Text] [Related]
19. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
[TBL] [Abstract][Full Text] [Related]
20. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
